Table 1.
Potential mechanisms by which VWF contributes to TBI-induced coagulation abnormalities
ULVWF functions as an adhesive ligand to mediate the interaction between pathologic BDEVs and endothelial cells. BDEVs with exposed phosphatidylserine bind coagulation factors, leading to a consumptive coagulopathy. |
ULVWF anchors to endothelial cells and tethers platelets, leukocytes and EVs to the endothelium, worsening inflammatory injury and serving as a nidus for microvascular thromboses. |
ULVWF released from injured endothelial cells overwhelms the cleavage capabilities of ADAMTS13, resulting in accumulation of uncleaved hyperadhesive VWF in circulation which then activate platelets and occludes the microvasculature. |
VWF indicates von Willebrand factor; ULVWF, ultra-large VWF; BDEVs, brain-derived extracellular vesicles.